Brian Pedlar, CEO, is not the type to speak in hyperbole, but is on record last year of stating his goal and belief of taking Covalon to $1B market cap. I'd be happy with 1/3 - 1/2 that. What I like is that him and Abe have both taken a small company from nothing to selling it for a half billion. In an important way Covalon is designed like a software firm that they were involved. Tough to get the large order, but once they do, customer keeps re-ordering. High margins and easily scalable.
Covalon has gone from a very high profile wound care specialist endorsing them at conferences to replacing their largest competitor, 3M, at the country level in Saudi Arabia. Time for major global market share growth!
Several exciting new products to be launched in the coming months, with Centaur freshly launched and already receiving licensing revenue.
News 
Market Data 
Discover 
